MULTIMODAL ANALGESIA
Clinical trials for MULTIMODAL ANALGESIA explained in plain language.
Never miss a new study
Get alerted when new MULTIMODAL ANALGESIA trials appear
Sign up with your email to follow new studies for MULTIMODAL ANALGESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New strategy aims to cut opioid use after prostate cancer surgery
Symptom relief Recruiting nowThis study is testing a new pain management plan for men recovering from robotic prostate cancer surgery. The plan uses multiple non-opioid pain medications first, with opioids available only if patients call to request them. Researchers want to see if this approach safely reduce…
Matched conditions: MULTIMODAL ANALGESIA
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New approach aims to cut opioid use after complex surgery
Symptom relief Recruiting nowThis study is testing whether giving a non-opioid pain medication called nefopam continuously after a major pancreatic surgery can help reduce the need for strong opioid painkillers and improve pain control. Researchers will compare this approach to two other standard pain manage…
Matched conditions: MULTIMODAL ANALGESIA
Phase: PHASE4 • Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
New drug aims to cut opioid use after hip surgery
Symptom relief Recruiting nowThis study is testing a new, FDA-approved non-opioid pain medication called Suzetrigine (Journavx™) for people having hip replacement surgery. The goal is to see if it can effectively manage post-surgery pain and reduce the need for traditional opioid painkillers, which can have …
Matched conditions: MULTIMODAL ANALGESIA
Phase: PHASE3 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Mar 13, 2026 15:06 UTC